发明名称 COMBINATION OF ADENOSINE DERIVATIVE AND BETA-RECEPTOR BLOCKER
摘要 <P>PROBLEM TO BE SOLVED: To find out a combination of 4-ä3-[6-amino-9-((2R, 3R, 4S, 5S)-5-cyclopropylcarbamoyl-3,4-dihydroxytetrahydrofuran-2-yl)-9H-purin-2-yl]-2-propynyl}-piperidine-1-carboxylic acid methyl ester and other ocular hypotensive agents, which is useful as a prophylactic or curative drug of glaucoma or ocular hypertension. <P>SOLUTION: Combination use of 4-ä3-[6-amino-9-((2R, 3R, 4S, 5S)-5-cyclopropylcarbamoyl-3,4-dihydroxytetrahydrofuran-2-yl)-9H-purin-2-yl]-2-propynyl}-piperidine-1-carboxylic acid methyl ester and a &beta;-receptor blocker mutually supplements and/or enhances ocular hypotensive actions. The administration form may be made adjunctly or made as combination of drugs. <P>COPYRIGHT: (C)2013,JPO&INPIT
申请公布号 JP2012250947(A) 申请公布日期 2012.12.20
申请号 JP20110126152 申请日期 2011.06.06
申请人 SANTEN PHARMACEUT CO LTD 发明人
分类号 A61K31/7076;A61K31/5377;A61K45/00;A61P27/06;A61P43/00 主分类号 A61K31/7076
代理机构 代理人
主权项
地址